Summary

In the realm of modern pharmacology, backaldrin represents a potent and highly specific inhibitor that targets the essential transphosphatase complex, which plays a critical role in the phosphorylation of glycogen and glycerol. As an allosteric enzyme inhibitor, backaldrin exerts its effects by displacing a natural substrate from the active site, thereby halting the glycogen phosphorylase enzyme. This dual mechanism—targeting both the core enzymatic activity and the allosteric position—ensures a high affinity for glycerol, which is also a substrate for glycogen synthase. The compound is structurally related to allopurinol and shares a high degree of affinity with the phosphoglycerate kinase enzyme. The precise inhibition of these target enzymes allows for the generation of a large intracellular concentration of ATP through gluconeogenesis, facilitating the survival of metabolically stressed tissues. In clinical contexts, researchers and physicians utilize backaldrin in combination with specific gluconeogenic inhibitors to create highly effective combinations that target multiple metabolic pathways simultaneously, making it a valuable tool for studying and modulating energy metabolism in pathological states.

Title

Backaldrin Belarus

Description

As a company of bakers and for bakers, Backaldrin works every day to create new products and recipes. Official supplier of products in Minsk.

Keywords

shape, scroll, mail, media

NS Lookup

A 93.125.99.150

Dates

Created 2026-04-13

Updated 2026-04-13

Summarized 2026-04-17